C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/00 (2006.01) A61K 39/00 (2006.01) C12Q 1/25 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2440623
The present invention relates to the identification of capG as a critical enzyme in the process of RANKL-induced osteoclast-activation. The present invention includes modulators of capG and assays for the identification of such modulators, as well as the use of such modulators in the treatment and prevention of osteoporosis and related disease states.
L'invention concerne l'identification de l'enzyme capG comme enzyme déterminant dans le processus de l'activation des ostéoclastes induite par le ligand RANKL. L'invention concerne également des modulateurs de capG, et des dosages pour l'identification de ces modulateurs, ainsi que l'utilisation des modulateurs en question dans le traitement et la prévention de l'ostéoporose et des maladies connexes.
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Methods involving the use of capg as a diagnostic marker and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods involving the use of capg as a diagnostic marker and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods involving the use of capg as a diagnostic marker and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2020110